Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-03-30

AUTHORS

N. Cézé, G. Thibault, G. Goujon, J. Viguier, H. Watier, E. Dorval, T. Lecomte

ABSTRACT

BackgroundLymphopenia is a predictor of the efficacy and hematological toxicity of chemotherapy in various advanced cancers. There is little data about this relationship in colorectal cancer. In this retrospective study, the influence of pretreatment lymphopenia on hematological toxicity and the efficacy of chemotherapy was investigated in colorectal cancer patients.Patients and methodsIn total, 260 patients were included in the study. Correlations between pre-treatment lymphopenia (lymphocyte count < 1,000/μl) and the occurrence of hematological toxicity and efficacy of first-line palliative chemotherapy were investigated.ResultsLymphopenia was found in 49/260 (19%) patients. Ten of these patients with lymphopenia (20.4%) experienced severe hematological toxicity compared with 17 of the remaining 211 (8%) patients (P = 0.01). Lymphopenia was identified as an independent factor for hematological toxicity. Among patients who received palliative chemotherapy, the objective response rate was significantly lower in lymphopenic patients than in the other patients (12.5% vs. 40.2%; P = 0.004). Lymphopenia was strongly associated with shorter progression-free survival (median 4 vs. 7 months; P = 0.033) and shorter overall survival (median 16 vs. 24 months, P = 0.024). Multivariate analysis revealed that lymphopenia had an independent effect on survival.ConclusionsOur findings show that lymphopenia is an independent predictive factor for both hematological toxicity and efficacy of chemotherapy in colorectal cancer. Pre-treatment lymphocyte count may represent a simple and new predictive biomarker of chemotherapy effects in colorectal cancer patients. More... »

PAGES

1305-1313

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-011-1610-3

DOI

http://dx.doi.org/10.1007/s00280-011-1610-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021758803

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21448592


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphopenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France", 
          "id": "http://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Fran\u00e7ois-Rabelais University, Tours, France", 
            "Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "C\u00e9z\u00e9", 
        "givenName": "N.", 
        "id": "sg:person.01051610356.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051610356.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UMR 6239 G\u00e9n\u00e9tique, Immunoth\u00e9rapie Chimie et Cancer, CNRS, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.4444.0", 
          "name": [
            "Fran\u00e7ois-Rabelais University, Tours, France", 
            "Immunology Laboratory, University Hospital of Tours, Tours, France", 
            "UMR 6239 G\u00e9n\u00e9tique, Immunoth\u00e9rapie Chimie et Cancer, CNRS, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thibault", 
        "givenName": "G.", 
        "id": "sg:person.01001566717.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001566717.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France", 
          "id": "http://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Fran\u00e7ois-Rabelais University, Tours, France", 
            "Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goujon", 
        "givenName": "G.", 
        "id": "sg:person.01003731322.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003731322.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France", 
          "id": "http://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Viguier", 
        "givenName": "J.", 
        "id": "sg:person.01171173235.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171173235.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UMR 6239 G\u00e9n\u00e9tique, Immunoth\u00e9rapie Chimie et Cancer, CNRS, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.4444.0", 
          "name": [
            "Fran\u00e7ois-Rabelais University, Tours, France", 
            "Immunology Laboratory, University Hospital of Tours, Tours, France", 
            "UMR 6239 G\u00e9n\u00e9tique, Immunoth\u00e9rapie Chimie et Cancer, CNRS, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Watier", 
        "givenName": "H.", 
        "id": "sg:person.01303233136.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303233136.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France", 
          "id": "http://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Fran\u00e7ois-Rabelais University, Tours, France", 
            "Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dorval", 
        "givenName": "E.", 
        "id": "sg:person.0647131407.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647131407.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service d\u2019H\u00e9patogastroent\u00e9rologie, H\u00f4pital Trousseau, CHRU de Tours, Tours Cedex 09, 37044, Tours, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Fran\u00e7ois-Rabelais University, Tours, France", 
            "Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France", 
            "UMR 6239 G\u00e9n\u00e9tique, Immunoth\u00e9rapie Chimie et Cancer, CNRS, Paris, France", 
            "Service d\u2019H\u00e9patogastroent\u00e9rologie, H\u00f4pital Trousseau, CHRU de Tours, Tours Cedex 09, 37044, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lecomte", 
        "givenName": "T.", 
        "id": "sg:person.01143615757.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143615757.53"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6600724", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020782963", 
          "https://doi.org/10.1038/sj.bjc.6600724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-008-0015-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043368994", 
          "https://doi.org/10.1245/s10434-008-0015-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/46218", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019747823", 
          "https://doi.org/10.1038/46218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200023040-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044089618", 
          "https://doi.org/10.2165/00002018-200023040-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.2000.1303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052754629", 
          "https://doi.org/10.1054/bjoc.2000.1303"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.2001.2011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007397119", 
          "https://doi.org/10.1054/bjoc.2001.2011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1312", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010042966", 
          "https://doi.org/10.1038/nm1312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35074122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001419011", 
          "https://doi.org/10.1038/35074122"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-03-30", 
    "datePublishedReg": "2011-03-30", 
    "description": "BackgroundLymphopenia is a predictor of the efficacy and hematological toxicity of chemotherapy in various advanced cancers. There is little data about this relationship in colorectal cancer. In this retrospective study, the influence of pretreatment lymphopenia on hematological toxicity and the efficacy of chemotherapy was investigated in colorectal cancer patients.Patients and methodsIn total, 260 patients were included in the study. Correlations between pre-treatment lymphopenia (lymphocyte count\u00a0<\u00a01,000/\u03bcl) and the occurrence of hematological toxicity and efficacy of first-line palliative chemotherapy were investigated.ResultsLymphopenia was found in 49/260 (19%) patients. Ten of these patients with lymphopenia (20.4%) experienced severe hematological toxicity compared with 17 of the remaining 211 (8%) patients (P\u00a0=\u00a00.01). Lymphopenia was identified as an independent factor for hematological toxicity. Among patients who received palliative chemotherapy, the objective response rate was significantly lower in lymphopenic patients than in the other patients (12.5% vs. 40.2%; P\u00a0=\u00a00.004). Lymphopenia was strongly associated with shorter progression-free survival (median 4 vs. 7\u00a0months; P\u00a0=\u00a00.033) and shorter overall survival (median 16 vs. 24\u00a0months, P\u00a0=\u00a00.024). Multivariate analysis revealed that lymphopenia had an independent effect on survival.ConclusionsOur findings show that lymphopenia is an independent predictive factor for both hematological toxicity and efficacy of chemotherapy in colorectal cancer. Pre-treatment lymphocyte count may represent a simple and new predictive biomarker of chemotherapy effects in colorectal cancer patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00280-011-1610-3", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "68"
      }
    ], 
    "keywords": [
      "colorectal cancer patients", 
      "Pre-treatment lymphopenia", 
      "hematological toxicity", 
      "efficacy of chemotherapy", 
      "cancer patients", 
      "palliative chemotherapy", 
      "colorectal cancer", 
      "first-line palliative chemotherapy", 
      "shorter progression-free survival", 
      "progression-free survival", 
      "severe hematological toxicity", 
      "objective response rate", 
      "independent predictive factors", 
      "shorter overall survival", 
      "new predictive biomarkers", 
      "pretreatment lymphopenia", 
      "lymphopenic patients", 
      "lymphocyte count", 
      "overall survival", 
      "advanced cancer", 
      "retrospective study", 
      "MethodsIn total", 
      "predictive factors", 
      "predictive biomarkers", 
      "prognostic biomarker", 
      "lymphopenia", 
      "chemotherapy", 
      "independent factors", 
      "chemotherapy effects", 
      "patients", 
      "response rate", 
      "multivariate analysis", 
      "cancer", 
      "little data", 
      "efficacy", 
      "independent effects", 
      "ConclusionsOur findings", 
      "survival", 
      "toxicity", 
      "biomarkers", 
      "factors", 
      "predictors", 
      "total", 
      "study", 
      "counts", 
      "effect", 
      "findings", 
      "occurrence", 
      "rate", 
      "correlation", 
      "data", 
      "relationship", 
      "analysis", 
      "influence", 
      "BackgroundLymphopenia", 
      "ResultsLymphopenia", 
      "Pre-treatment lymphocyte count"
    ], 
    "name": "Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy", 
    "pagination": "1305-1313", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021758803"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-011-1610-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21448592"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-011-1610-3", 
      "https://app.dimensions.ai/details/publication/pub.1021758803"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_536.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00280-011-1610-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-011-1610-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-011-1610-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-011-1610-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-011-1610-3'


 

This table displays all metadata directly associated to this object as RDF triples.

257 TRIPLES      22 PREDICATES      104 URIs      88 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-011-1610-3 schema:about N0b4e61685d564b339baba8668e72afc9
2 N11e5cad7364b436c85f6278f15e63763
3 N2991469b909747bd986143aebef122ec
4 N44a997d8d8984171a9c65a0d48e4fabc
5 N689796b6f4a44a4b85432664e446881c
6 N9beec797943f4609825fb811e28aa181
7 Nbfa2350c6cc741a980f7396d6ec3b2a2
8 Nce31cdb2701a4c1489b62e31fec81b3b
9 Nd6596459c5364d85a66e69c35c4f4a47
10 Nda6b795d2a294ea28cb1365ac095a672
11 Ndb50736cab6e43c485a973a7cdbb0e8b
12 Nf92d6f0938fe4fd4a25b4abd9ca2b058
13 Nff2115c6918f4482a5495d481bb23208
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Nd472dcf9c2b34ce2999c78d9daf8f676
17 schema:citation sg:pub.10.1038/35074122
18 sg:pub.10.1038/46218
19 sg:pub.10.1038/nm1312
20 sg:pub.10.1038/sj.bjc.6600724
21 sg:pub.10.1054/bjoc.2000.1303
22 sg:pub.10.1054/bjoc.2001.2011
23 sg:pub.10.1245/s10434-008-0015-y
24 sg:pub.10.2165/00002018-200023040-00001
25 schema:datePublished 2011-03-30
26 schema:datePublishedReg 2011-03-30
27 schema:description BackgroundLymphopenia is a predictor of the efficacy and hematological toxicity of chemotherapy in various advanced cancers. There is little data about this relationship in colorectal cancer. In this retrospective study, the influence of pretreatment lymphopenia on hematological toxicity and the efficacy of chemotherapy was investigated in colorectal cancer patients.Patients and methodsIn total, 260 patients were included in the study. Correlations between pre-treatment lymphopenia (lymphocyte count < 1,000/μl) and the occurrence of hematological toxicity and efficacy of first-line palliative chemotherapy were investigated.ResultsLymphopenia was found in 49/260 (19%) patients. Ten of these patients with lymphopenia (20.4%) experienced severe hematological toxicity compared with 17 of the remaining 211 (8%) patients (P = 0.01). Lymphopenia was identified as an independent factor for hematological toxicity. Among patients who received palliative chemotherapy, the objective response rate was significantly lower in lymphopenic patients than in the other patients (12.5% vs. 40.2%; P = 0.004). Lymphopenia was strongly associated with shorter progression-free survival (median 4 vs. 7 months; P = 0.033) and shorter overall survival (median 16 vs. 24 months, P = 0.024). Multivariate analysis revealed that lymphopenia had an independent effect on survival.ConclusionsOur findings show that lymphopenia is an independent predictive factor for both hematological toxicity and efficacy of chemotherapy in colorectal cancer. Pre-treatment lymphocyte count may represent a simple and new predictive biomarker of chemotherapy effects in colorectal cancer patients.
28 schema:genre article
29 schema:inLanguage en
30 schema:isAccessibleForFree false
31 schema:isPartOf N27d731c01ab247999e6606ebfe86717a
32 Ne018d8e3ee93462cb4cd68c1f5806863
33 sg:journal.1088364
34 schema:keywords BackgroundLymphopenia
35 ConclusionsOur findings
36 MethodsIn total
37 Pre-treatment lymphocyte count
38 Pre-treatment lymphopenia
39 ResultsLymphopenia
40 advanced cancer
41 analysis
42 biomarkers
43 cancer
44 cancer patients
45 chemotherapy
46 chemotherapy effects
47 colorectal cancer
48 colorectal cancer patients
49 correlation
50 counts
51 data
52 effect
53 efficacy
54 efficacy of chemotherapy
55 factors
56 findings
57 first-line palliative chemotherapy
58 hematological toxicity
59 independent effects
60 independent factors
61 independent predictive factors
62 influence
63 little data
64 lymphocyte count
65 lymphopenia
66 lymphopenic patients
67 multivariate analysis
68 new predictive biomarkers
69 objective response rate
70 occurrence
71 overall survival
72 palliative chemotherapy
73 patients
74 predictive biomarkers
75 predictive factors
76 predictors
77 pretreatment lymphopenia
78 prognostic biomarker
79 progression-free survival
80 rate
81 relationship
82 response rate
83 retrospective study
84 severe hematological toxicity
85 shorter overall survival
86 shorter progression-free survival
87 study
88 survival
89 total
90 toxicity
91 schema:name Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy
92 schema:pagination 1305-1313
93 schema:productId N152aaad3ffc441f7aa30934394ca46a2
94 Nbc2f326cd98c494cb598797245aa279f
95 Ndd7364c60b3d412288f3bbd61b33daa6
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021758803
97 https://doi.org/10.1007/s00280-011-1610-3
98 schema:sdDatePublished 2021-11-01T18:15
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher N8a0057a554bd4881b45932d75ecdffda
101 schema:url https://doi.org/10.1007/s00280-011-1610-3
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N0b4e61685d564b339baba8668e72afc9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Cohort Studies
107 rdf:type schema:DefinedTerm
108 N11e5cad7364b436c85f6278f15e63763 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Adult
110 rdf:type schema:DefinedTerm
111 N1512e04107534114a4d579d7e8e37bd8 rdf:first sg:person.0647131407.91
112 rdf:rest N98e4fcf91a8a4ccc9f42fe5dc0325b85
113 N152aaad3ffc441f7aa30934394ca46a2 schema:name pubmed_id
114 schema:value 21448592
115 rdf:type schema:PropertyValue
116 N27d731c01ab247999e6606ebfe86717a schema:volumeNumber 68
117 rdf:type schema:PublicationVolume
118 N2991469b909747bd986143aebef122ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Antineoplastic Agents
120 rdf:type schema:DefinedTerm
121 N44a997d8d8984171a9c65a0d48e4fabc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Male
123 rdf:type schema:DefinedTerm
124 N51a188e124d745c993661bc9d0a5570a rdf:first sg:person.01001566717.64
125 rdf:rest N91898173d9e94226b46b07c6f6820b02
126 N689796b6f4a44a4b85432664e446881c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Biomarkers, Tumor
128 rdf:type schema:DefinedTerm
129 N8a0057a554bd4881b45932d75ecdffda schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 N91898173d9e94226b46b07c6f6820b02 rdf:first sg:person.01003731322.99
132 rdf:rest Naba256b750e142b985e11406ef3aebba
133 N98e4fcf91a8a4ccc9f42fe5dc0325b85 rdf:first sg:person.01143615757.53
134 rdf:rest rdf:nil
135 N9beec797943f4609825fb811e28aa181 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Colorectal Neoplasms
137 rdf:type schema:DefinedTerm
138 Naba256b750e142b985e11406ef3aebba rdf:first sg:person.01171173235.73
139 rdf:rest Nc92411d67ba442f6bcb9f2950db5d3f7
140 Nbc2f326cd98c494cb598797245aa279f schema:name dimensions_id
141 schema:value pub.1021758803
142 rdf:type schema:PropertyValue
143 Nbfa2350c6cc741a980f7396d6ec3b2a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Humans
145 rdf:type schema:DefinedTerm
146 Nc92411d67ba442f6bcb9f2950db5d3f7 rdf:first sg:person.01303233136.42
147 rdf:rest N1512e04107534114a4d579d7e8e37bd8
148 Nce31cdb2701a4c1489b62e31fec81b3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Retrospective Studies
150 rdf:type schema:DefinedTerm
151 Nd472dcf9c2b34ce2999c78d9daf8f676 rdf:first sg:person.01051610356.29
152 rdf:rest N51a188e124d745c993661bc9d0a5570a
153 Nd6596459c5364d85a66e69c35c4f4a47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Aged
155 rdf:type schema:DefinedTerm
156 Nda6b795d2a294ea28cb1365ac095a672 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Middle Aged
158 rdf:type schema:DefinedTerm
159 Ndb50736cab6e43c485a973a7cdbb0e8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Lymphopenia
161 rdf:type schema:DefinedTerm
162 Ndd7364c60b3d412288f3bbd61b33daa6 schema:name doi
163 schema:value 10.1007/s00280-011-1610-3
164 rdf:type schema:PropertyValue
165 Ne018d8e3ee93462cb4cd68c1f5806863 schema:issueNumber 5
166 rdf:type schema:PublicationIssue
167 Nf92d6f0938fe4fd4a25b4abd9ca2b058 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Prognosis
169 rdf:type schema:DefinedTerm
170 Nff2115c6918f4482a5495d481bb23208 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Female
172 rdf:type schema:DefinedTerm
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
177 schema:name Oncology and Carcinogenesis
178 rdf:type schema:DefinedTerm
179 sg:journal.1088364 schema:issn 0344-5704
180 1432-0843
181 schema:name Cancer Chemotherapy and Pharmacology
182 schema:publisher Springer Nature
183 rdf:type schema:Periodical
184 sg:person.01001566717.64 schema:affiliation grid-institutes:grid.4444.0
185 schema:familyName Thibault
186 schema:givenName G.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001566717.64
188 rdf:type schema:Person
189 sg:person.01003731322.99 schema:affiliation grid-institutes:grid.411167.4
190 schema:familyName Goujon
191 schema:givenName G.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003731322.99
193 rdf:type schema:Person
194 sg:person.01051610356.29 schema:affiliation grid-institutes:grid.411167.4
195 schema:familyName Cézé
196 schema:givenName N.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051610356.29
198 rdf:type schema:Person
199 sg:person.01143615757.53 schema:affiliation grid-institutes:None
200 schema:familyName Lecomte
201 schema:givenName T.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143615757.53
203 rdf:type schema:Person
204 sg:person.01171173235.73 schema:affiliation grid-institutes:grid.411167.4
205 schema:familyName Viguier
206 schema:givenName J.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171173235.73
208 rdf:type schema:Person
209 sg:person.01303233136.42 schema:affiliation grid-institutes:grid.4444.0
210 schema:familyName Watier
211 schema:givenName H.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303233136.42
213 rdf:type schema:Person
214 sg:person.0647131407.91 schema:affiliation grid-institutes:grid.411167.4
215 schema:familyName Dorval
216 schema:givenName E.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647131407.91
218 rdf:type schema:Person
219 sg:pub.10.1038/35074122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001419011
220 https://doi.org/10.1038/35074122
221 rdf:type schema:CreativeWork
222 sg:pub.10.1038/46218 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019747823
223 https://doi.org/10.1038/46218
224 rdf:type schema:CreativeWork
225 sg:pub.10.1038/nm1312 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010042966
226 https://doi.org/10.1038/nm1312
227 rdf:type schema:CreativeWork
228 sg:pub.10.1038/sj.bjc.6600724 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020782963
229 https://doi.org/10.1038/sj.bjc.6600724
230 rdf:type schema:CreativeWork
231 sg:pub.10.1054/bjoc.2000.1303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052754629
232 https://doi.org/10.1054/bjoc.2000.1303
233 rdf:type schema:CreativeWork
234 sg:pub.10.1054/bjoc.2001.2011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007397119
235 https://doi.org/10.1054/bjoc.2001.2011
236 rdf:type schema:CreativeWork
237 sg:pub.10.1245/s10434-008-0015-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1043368994
238 https://doi.org/10.1245/s10434-008-0015-y
239 rdf:type schema:CreativeWork
240 sg:pub.10.2165/00002018-200023040-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044089618
241 https://doi.org/10.2165/00002018-200023040-00001
242 rdf:type schema:CreativeWork
243 grid-institutes:None schema:alternateName Service d’Hépatogastroentérologie, Hôpital Trousseau, CHRU de Tours, Tours Cedex 09, 37044, Tours, France
244 schema:name Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France
245 François-Rabelais University, Tours, France
246 Service d’Hépatogastroentérologie, Hôpital Trousseau, CHRU de Tours, Tours Cedex 09, 37044, Tours, France
247 UMR 6239 Génétique, Immunothérapie Chimie et Cancer, CNRS, Paris, France
248 rdf:type schema:Organization
249 grid-institutes:grid.411167.4 schema:alternateName Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France
250 schema:name Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours, Tours, France
251 François-Rabelais University, Tours, France
252 rdf:type schema:Organization
253 grid-institutes:grid.4444.0 schema:alternateName UMR 6239 Génétique, Immunothérapie Chimie et Cancer, CNRS, Paris, France
254 schema:name François-Rabelais University, Tours, France
255 Immunology Laboratory, University Hospital of Tours, Tours, France
256 UMR 6239 Génétique, Immunothérapie Chimie et Cancer, CNRS, Paris, France
257 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...